1 |
Hyun SH,Kim HS,Choi SH,et al.Intratumoral heterogeneity of(18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma[J].Eur J Nucl Med Mol Imaging,2016,43(8):1461-1468.
|
2 |
Sollini M,Antunovic L,Chiti A,et al.Towards clinical application of image mining:a systematic review on artificial intelligence and radiomics[J].Eur J Nucl Med Mol Imaging,2019,46(13):2656-2672.
|
3 |
Mayerhoefer ME,Materka A,Langs G,et al.Introduction to Radiomics[J].J Nucl Med,2020,61(4):488-495.
|
4 |
Lambin P,Rios-Velazquez E,Leijenaar R,et al.Radiomics:extracting more information from medical images using advanced feature analysis[J].Eur J Cancer,2012,48(4):441-446.
|
5 |
Li P,Wang X,Xu C,et al.18F-FDG PET/CT radiomic predictors of pathologic complete response(pCR)to neoadjuvant chemotherapy in breast cancer patients[J].Eur J Nucl Med Mol Imaging,2020,47(5):1116-1126.
|
6 |
Jiang C,Zhao L,Xin B,et al.18F-FDG PET/CT radiomic analysis for classifying and predicting microvascular invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J].Quantitative Imaging in Medicine and Surgery,2022,12(8):4135-4150.
|
7 |
Zwanenburg A,Vallières M,Abdalah M A,et al.The Image Biomarker Standardization Initiative:Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping[J].Radiology,2020,295(2):328-338.
|
8 |
Castiglioni I,Rundo L,Codari M,et al.AI applications to medical images:From machine learning to deep learning[J].Phy Med,2021,83:9-24.
|
9 |
Obermeyer Z,Emanuel EJ.Predicting the Future-Big Data,Machine Learning,and Clinical Medicine[J].New Engl J Med,2016,375(13):1216-1219.
|
10 |
Cuaron J,Dunphy M,Rimner A.Role of FDG-PET scans in staging,response assessment,and follow-up care for non-small cell lung cancer[J].Front Oncol,2012,2:208.
|
11 |
Li J,Liu Y,Dong W,et al.Identifying 18F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module[J].Quantitative Imaging in Medicine and Surgery,2022,12(3):1893-1908.
|
12 |
Krarup MMK,Nygård L,Vogelius IR,et al.Heterogeneity in tumours:Validating the use of radiomic features on 18F-FDG PET/CT scans of lung cancer patients as a prognostic tool[J].Radiother Oncol,2020,144:72-78.
|
13 |
Kirienko M,Cozzi L,Antunovic L,et al.Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery[J].Eur J Nucl Med Mol Imaging,2018,45(2):207-217.
|
14 |
Yang L,Xu P,Li M,et al.PET/CT Radiomic Features:A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs[J].Front Oncol,2022,12:894323.
|
15 |
Sepehri S,Tankyevych O,Upadhaya T,et al.Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage Ⅱ-Ⅲ Non-Small Cell Lung Cancer[J].Diagnostics(Basel,Switzerland),2021,11(4):675.
|
16 |
Chen YH,Wang TF,Chu SC,et al.Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma[J].PloS One,2020,15(12):e0244502.
|
17 |
Yang B,Ji HS,Zhou CS,et al.18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma[J].Translational Lung Cancer Research,2020,9(3):563-574.
|
18 |
Huang SY,Franc BL,Harnish RJ,et al.Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis[J].NPJ Breast Cancer,2018,4:24.
|
19 |
Gómez OV,Herraiz JL,Udías JM,et al.Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on[18F]F-FDG PET/CT Radiomic Features for Metabolic Response Prediction of Metastatic Breast Cancer Lesions[J].Cancers,2022,14(12):2922.
|
20 |
Roy S,Whitehead TD,Li S,et al.Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer[J].Eur J Nucl Med Mol Imaging,2022,49(2):550-562.
|
21 |
Jiang C,Li A,Teng Y,et al.Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma[J].Eur J Nucl Med Mol Imaging,2022,49(8):2902-2916.
|
22 |
Aide N,Fruchart C,Nganoa C,et al.Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy[J].European Radiology,2020,30(8):4623-4632.
|
23 |
Lue KH,Wu YF,Lin HH,et al.Prognostic Value of Baseline Radiomic Features of 18 F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma[J].Diagnostics(Basel),2020,11(1):36.
|
24 |
Zhou Y,Li J,Zhang X,et al.Prognostic Value of Radiomic Features of 18F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells[J].Front Oncol,2022,12:834288.
|
25 |
Lue KH,Wu YF,Liu SH,et al.Prognostic Value of Pretreatment Radiomic Features of 18F-FDG PET in Patients With Hodgkin Lymphoma[J].Clinical Nuclear Medicine,2019,44(10):e559-e565.
|
26 |
Zhou Y,Zhu Y,Chen Z,et al.Radiomic Features of 18F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes[J].Contrast Media & Molecular Imaging,2021,2021:6347404.
|
27 |
Wang H,Zhao S,Li L,et al.Development and validation of an 18F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma[J].European Radiology,2020,30(10):5578-5587.
|
28 |
Zhou Y,Ma XL,Pu LT,et al.Prediction of Overall Survival and Progression-Free Survival by the 18F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma[J].Contrast Media & Molecular Imaging,2019,2019:5963607.
|
29 |
Gerstner ER,Zhang Z,Fink JR,et al.ACRIN 6684:Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI[J].Clinical Cancer Research,2016,22(20):5079-5086.
|
30 |
Muzi M,Wolsztynski E,Fink JR,et al.Assessment of the Prognostic Value of Radiomic Features in 18F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients:Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial[J].Tomography,2020,6(1):14-22.
|
31 |
Feliciani G,Fioroni F,Grassi E,et al.Radiomic Profiling of Head and Neck Cancer:18F-FDG PET Texture Analysis as Predictor of Patient Survival[J].Contrast Media & Molecular Imaging,2018,2018:3574310.
|
32 |
Dmytriw AA,Ortega C,Anconina R,et al.Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT:Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up[J].Cancers,2022,14(13):3105.
|
33 |
Brodin N P,Velten C,Lubin J,et al.A positron emission tomography radiomic signature for distant metastases risk in oropharyngeal cancer patients treated with definitive chemoradiotherapy[J].Physics and Imaging in Radiation Oncology,2022,21:72-77.
|
34 |
Nakajo M,Kawaji K,Nagano H,et al.The Usefulness of Machine Learning-Based Evaluation of Clinical and Pretreatment[18F]-FDG-PET/CT Radiomic Features for Predicting Prognosis in Hypopharyngeal Cancer[J].Mol Imaging Biol,2022.
|
35 |
Rishi A,Zhang GG,Yuan Z,et al.Pretreatment CT and 18 F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer[J].J Med Imaging Radiat Oncol,2021,65(1):102-111.
|
36 |
Yh C,Kh L,Sc C,et al.Combining the radiomic features and traditional parameters of 18 F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery[J].Ann Nucl Med,2019,33(9):657-670.
|
37 |
Jiang Y,Yuan Q,Lv W,et al.Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits[J].Theranostics,2018,8(21):5915-5928.
|
38 |
Xue XQ,Yu WJ,Shi X,et al.18F-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer[J].Front Oncol,2022,12:911168.
|
39 |
Blanc-Durand P,Van Der Gucht A,Jreige M,et al.Signature of survival:a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma[J].Oncotarget,2018,9(4):4549-4558.
|
40 |
Lee JW,Na JO,Kang DY,et al.Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection[J].Clinical Lung Cancer,2017,18(2):198-206.
|
41 |
Lee JW,Ban MJ,Park JH,et al.Effect of F-18 Fluorodeoxyglucose Uptake by Bone Marrow on the Prognosis of Head and Neck Squamous Cell Carcinoma[J].J Clin Med,2019,8(8):E1169.
|
42 |
Lee JW,Park SH,Ahn H,et al.Predicting Survival in Patients with Pancreatic Cancer by Integrating Bone Marrow FDG Uptake and Radiomic Features of Primary Tumor in PET/CT[J].Cancers,2021,13(14):3563.
|
43 |
Mori M,Passoni P,Incerti E,et al.Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer[J].Radiother Oncol,2020,153:258-264.
|
44 |
Mapelli P,Bezzi C,Palumbo D,et al.68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours[J].Eur J Nucl Med Mol Imaging,2022,49(7):2352-2363.
|
45 |
Lv L,Xin B,Hao Y,et al.Radiomic analysis for predicting prognosis of colorectal cancer from preoperative 18F-FDG PET/CT[J].J Transl Med,2022,20(1):66.
|
46 |
Manfredi S,Lepage C,Hatem C,et al.Epidemiology and management of liver metastases from colorectal cancer[J].Ann Surg,2006,244(2):254-259.
|
47 |
Rahmim A,Bak-Fredslund KP,Ashrafinia S,et al.Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features[J].Eur J Radiol,2019,113:101-109.
|
48 |
Wilkinson JR,Morris EJA,Downing A,et al.The rising incidence of anal cancer in England 1990-2010:a population-based study[J].Colorectal Dis,2014,16(7):O234-239.
|
49 |
Brown P J,Zhong J,Frood R,et al.Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT[J].Eur J Nucl Med Mol Imaging,2019,46(13):2790-2799.
|
50 |
Nakajo M,Jinguji M,Tani A,et al.Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment[18F]-FDG PET/CT to Predict Prognosis of Patients with Endometrial Cancer[J].Mol Imaging Biol,2021,23(5):756-765.
|
51 |
Nakajo M,Jinguji M,Tani A,et al.Machine learning based evaluation of clinical and pretreatment 18F-FDG-PET/CT radiomic features to predict prognosis of cervical cancer patients[J].Abdominal Radiology(New York),2022,47(2):838-847.
|
52 |
Martone ME.FORCE11:Building the Future for Research Communications and e-Scholarship[J].BioScience,2015,65(7):635.
|
53 |
Wilkinson MD,Dumontier M,Aalbersberg IJJ,et al.The FAIR Guiding Principles for scientific data management and stewardship[J].Scientific Data,2016,3:160018.
|
54 |
Lambin P,Leijenaar RTH,Deist TM,et al.Radiomics:the bridge between medical imaging and personalized medicine[J].Nat Rev Clin Oncol,2017,14(12):749-762.
|
55 |
Hosny A,Parmar C,Quackenbush J,et al.Artificial intelligence in radiology[J].Nat Rev Cancer,2018,18(8):500-510.
|
56 |
Manafi-Farid R,Karamzade-Ziarati N,Vali R,et al.2-[18F]FDG PET/CT radiomics in lung cancer:An overview of the technical aspect and its emerging role in management of the disease[J].Methods,2021,188:84-97.
|
57 |
Zwanenburg A.Radiomics in nuclear medicine:robustness,reproducibility,standardization,and how to avoid data analysis traps and replication crisis[J].Eur J Nucl Med Mol Imaging,2019,46(13):2638-2655.
|
58 |
Clark K,Vendt B,Smith K,et al.The Cancer Imaging Archive(TCIA):maintaining and operating a public information repository[J].Journal of Digital Imaging,2013,26(6):1045-1057.
|
59 |
Buckler A J,Bresolin L,Dunnick NR,et al.A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging[J].Radiology,2011,258(3):906-914.
|
60 |
Deist TM,Jochems A,van Soest J,et al.Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care:euroCAT[J].Clin Transl Radiat Oncol,2017,4:24-31.
|
61 |
Pesapane F,VolontéC,Codari M,et al.Artificial intelligence as a medical device in radiology:ethical and regulatory issues in Europe and the United States[J].Insights Imaging,2018,9(5):745-753.
|
62 |
Kaissis GA,Makowski MR,Rückert D,et al.Secure,privacy-preserving and federated machine learning in medical imaging[J].Nature Machine Intelligence,2020,2(6):305-311.
|
63 |
Rieke N,Hancox J,Li W,et al.The future of digital health with federated learning[J].NPJ Digit Med,2020,3:119.
|